Hill Happenings
Tracking the Hill's briefings, receptions, workshops, and more.



Tracking the Hill's briefings, luncheons, receptions, and more.
Filter by tags: House SideSenate Side | After 5Food

Back to All Events

The Price of Progress: A Policy Discussion of Drug Innovation, Access, and Costs

  • 485 Russell Senate Office Building (map)

June 19 – 12:00 to 1:30 PM
Russell Senate Office Building– Room 485
Keynote Speaker to Be Announced
Study to Be Released

While the U.S. leads the world in medical innovations and patient access, escalating drug prices are generating a fierce political and policy debate. One proposed approach to reducing drug prices for American consumers that is attracting considerable attention from policymakers is International Reference Pricing (IRP), the practice of pegging one country’s drug prices to what other countries are paying for similar medicines. Do price controls make sense, and will they work? What would be the ripple effects of IRP on investments, R&D and patient access? 

Join the American Consumer Institute on June 19th for a distinguished panel of experts who will discuss recent proposals to rein in drug pricing, the linkages between drug pricing and investment, and the consequences of legislating drug market prices. The panelists will include:

  • Dr. Krisztina Pusok, Director, American Consumer Institute (moderating)

  • Timothy Lee, Senior Vice President, Center for Individual Freedom

  • Patrick Hedger, Research Fellow, Competitive Enterprise Institute

RSPV at Eventbrite

Lunch Will Be Provided 

Open to the Public